Shao, Hui <br/><br/>
Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus.  [electronic resource] 

 -  Current medical research and opinion  02 2017 
 - 359-369 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1080/03007995.2016.1257978  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzhydryl Compounds--economics<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Glucosides--economics<br/>Health Care Costs<br/>Humans<br/>Hypoglycemic Agents--economics<br/>Models, Economic<br/>Quality-Adjusted Life Years<br/>Sulfonylurea Compounds--economics